Published in J Clin Psychopharmacol on April 01, 1990
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. Int J Neuropsychopharmacol (2009) 2.33
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT (2013) 1.62
The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures. Eur Neuropsychopharmacol (2006) 1.58
Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention. J ECT (2008) 1.47
Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology (2013) 1.46
Current issues in the classification of psychotic major depression. Schizophr Bull (2007) 1.22
Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Mol Psychiatry (2012) 1.16
Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment. J Affect Disord (2008) 1.12
Electroacupuncture for residual insomnia associated with major depressive disorder: a randomized controlled trial. Sleep (2011) 1.07
Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT. J Psychiatr Pract (2009) 1.06
Regional electric field induced by electroconvulsive therapy in a realistic finite element head model: influence of white matter anisotropic conductivity. Neuroimage (2011) 1.01
Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence (2012) 1.01
Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment. Psychiatry Res (2009) 0.94
Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response? J Affect Disord (2012) 0.93
Electroconvulsive therapy: Part II: a biopsychosocial perspective. J Psychiatr Pract (2009) 0.93
Challenges in the treatment of major depressive disorder with psychotic features. Schizophr Bull (2013) 0.92
Mechanisms of antidepressant resistance. Front Pharmacol (2013) 0.92
Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety (2011) 0.90
Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder. Brain Stimul (2011) 0.88
Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. Depress Anxiety (2012) 0.86
Persistent delusional theme over 13 episodes of psychotic depression. Acta Neuropsychiatr (2013) 0.85
The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults. Bipolar Disord (2010) 0.83
The prednisolone suppression test in depression: dose-response and changes with antidepressant treatment. Psychoneuroendocrinology (2010) 0.83
Predictors of time to relapse/recurrence after electroconvulsive therapy in patients with major depressive disorder: a population-based cohort study. Depress Res Treat (2011) 0.83
Treatment of depressed bipolar patients with alcohol use disorders: plenty of room for improvement. J Affect Disord (2008) 0.81
Combination rapid transcranial magnetic stimulation in treatment refractory depression. Neuropsychiatr Dis Treat (2006) 0.80
A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients. Psychopharmacology (Berl) (2004) 0.80
Methodology and preliminary results from the neurobiology of late-life depression study. Int Psychogeriatr (2015) 0.79
"Say, are you psychiatrists still using ECT?". CMAJ (1997) 0.77
Resting-state functional connectivity of antero-medial prefrontal cortex sub-regions in major depression and relationship to emotional intelligence. Int J Neuropsychopharmacol (2015) 0.76
Number of risk genotypes is a risk factor for major depressive disorder: a case control study. Behav Brain Funct (2006) 0.76
Relapse prevention after index electroconvulsive therapy in treatment-resistant depression. Ann Clin Psychiatry (2014) 0.76
Electroconvulsive therapy-induced mania: a case report. J Med Case Rep (2009) 0.75
[Electroconvulsive therapy as maintenance therapy and for prevention of recurrence in psychiatric disorders and Parkinson disease]. Wien Klin Wochenschr (2003) 0.75
Negative Affectivity, Aging, and Depression: Results From the Neurobiology of Late-Life Depression (NBOLD) Study. Am J Geriatr Psychiatry (2017) 0.75
Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed? Psychopharmacology (Berl) (2005) 0.75
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA (2001) 4.34
Physical properties and quantification of the ECT stimulus: I. Basic principles. Convuls Ther (1994) 4.18
Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul (2008) 3.50
Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med (1993) 3.45
Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry (2006) 3.44
A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry (2000) 3.06
Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry (1993) 2.80
Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology (2002) 2.79
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Smith-Fineman-Myers syndrome in two brothers. Am J Med Genet (1991) 2.70
Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet (2001) 2.56
Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol (2001) 2.32
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23
Mutation of the gene encoding the ROR2 tyrosine kinase causes autosomal recessive Robinow syndrome. Nat Genet (2000) 2.03
The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry (2000) 1.91
Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. Am J Geriatr Psychiatry (1999) 1.77
A clinical and genetic study of the Say/Barber/Biesecker/Young-Simpson type of Ohdo syndrome. Clin Genet (2008) 1.71
Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet (2001) 1.66
Treatment of the modal patient: does one size fit nearly all? J ECT (2001) 1.61
Cognitive spatial processing and the regulation of posture. J Exp Psychol Hum Percept Perform (1985) 1.58
Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment. Br J Psychiatry (1996) 1.56
Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors. J ECT (2000) 1.56
The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome. Arch Gen Psychiatry (1996) 1.53
Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry (1987) 1.51
Seizure threshold in electroconvulsive therapy. Effects of sex, age, electrode placement, and number of treatments. Arch Gen Psychiatry (1987) 1.51
Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Arch Gen Psychiatry (2011) 1.50
Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's disease. J Nucl Med (1993) 1.45
Low use of neuroleptic drugs in the treatment of psychotic major depression. Am J Psychiatry (1997) 1.44
Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. I. Global analyses. J ECT (2000) 1.44
A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol (2005) 1.42
Does ECT permanently alter seizure threshold? Biol Psychiatry (1993) 1.41
Prolactin response to electroconvulsive therapy: effects of electrode placement and stimulus dosage. Biol Psychiatry (1998) 1.38
Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activities. Antimicrob Agents Chemother (2001) 1.37
Predictors of retrograde amnesia following ECT. Am J Psychiatry (1995) 1.35
Macrocephaly with cutis marmorata, haemangioma and syndactyly--a distinctive overgrowth syndrome. Clin Dysmorphol (1997) 1.33
SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype. J Med Genet (2009) 1.32
Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res (1990) 1.32
Citalopram for agitation in Alzheimer's disease: design and methods. Alzheimers Dement (2012) 1.31
A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. Am J Hum Genet (2007) 1.31
Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am (1991) 1.27
Diabetes mellitus in schizophrenic patients. Compr Psychiatry (1996) 1.27
Localisation of the MRX3 gene for non-specific X linked mental retardation. J Med Genet (1991) 1.27
Phenotypic variability and asymmetry of Rieger syndrome associated with PITX2 mutations. Invest Ophthalmol Vis Sci (2000) 1.26
Olfactory dysfunction as a predictor of neurodegenerative disease. Curr Neurol Neurosci Rep (2006) 1.26
Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients. J Med Genet (2005) 1.26
The clinical picture of the Börjeson-Forssman-Lehmann syndrome in males and heterozygous females with PHF6 mutations. Clin Genet (2004) 1.25
Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology (2002) 1.25
Change in cognitive functioning following acute antidepressant treatment in late-life depression. Am J Geriatr Psychiatry (2009) 1.23
Studies of dosage, seizure threshold, and seizure duration in ECT. Biol Psychiatry (1987) 1.20
Lack of pharmacokinetic interaction between nelfinavir and nevirapine. AIDS (1998) 1.19
Psychopathological features in Alzheimer's disease: course and relationship with cognitive status. J Am Geriatr Soc (2003) 1.12
Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate. Clin Infect Dis (1999) 1.10
How many X-linked genes for non-specific mental retardation (MRX) are there? Am J Med Genet (1996) 1.10
Multiple mechanisms are implicated in the generation of 5q35 microdeletions in Sotos syndrome. J Med Genet (2005) 1.06
Pericentromeric genes for non-specific X-linked mental retardation (MRX). Am J Med Genet (1994) 1.05
Nomenclature guidelines for X-linked mental retardation. Am J Med Genet (1992) 1.04
ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord (2001) 1.03
Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry (1999) 1.03
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. Int J Geriatr Psychiatry (2008) 1.01
Too ill to learn: double jeopardy in education for sick children. J R Soc Med (2000) 1.00
The adult phenotype in Costello syndrome. Am J Med Genet A (2005) 0.99
Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiatry (1983) 0.99
Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. Arch Gen Psychiatry (1990) 0.98
Cognitive consequences of low-dosage electroconvulsive therapy. Ann N Y Acad Sci (1986) 0.97
Models of sexual selection on a quantitative genetic trait when preference is acquired by sexual imprinting. Evolution (2001) 0.96
Fictitious breast cancer family history. Lancet (1996) 0.95
Cardiac arrest during ECT modified by beta-adrenergic blockade. Am J Psychiatry (1984) 0.94
Assessment of late life depression. Biol Psychiatry (2002) 0.93
The development of mania and organic euphoria during ECT. J Clin Psychiatry (1988) 0.92
ECT in a patient with aortic aneurysm. J Clin Psychiatry (1990) 0.92
A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology (1996) 0.91
Severe neonatal manifestations of Costello syndrome. J Med Genet (2007) 0.91
Low testosterone levels in elderly men with dysthymic disorder. Am J Psychiatry (2002) 0.91